Please login or sign up to post and edit reviews.
JP Morgan Healthcare Conference Highlights - Publication Date |
- Jan 20, 2024
- Episode Duration |
- 00:26:31
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss:
- Biogen’s next shot at an Alzheimer’s treatment.
- Why companies can’t “muscle their way” into making new molecules.
- How NVIDIA could change drug development.
- Moderna’s vaccine strategy
Companies discussed: LLY, NVO, GPCR, NVDA, DXCM, NVDA, BIIB, GEHC, MRNA, NVCR, VRTX
Host: Deidre Woollard
Guest: Karl Thiel
Producer: Ricky Mulvey
Engineer: Tim Sparks
Learn more about your ad choices. Visit
megaphone.fm/adchoicesThis episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review